May 15 |
Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
|
May 14 |
Gilead Sciences, Inc. (GILD) BofA Securities 2024 Health Care Conference (Transcript)
|
May 14 |
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
|
May 14 |
Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
|
May 13 |
One stock is dragging down the S&P 500's earnings growth
|
May 9 |
Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
|
May 9 |
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
|
May 9 |
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
|
May 9 |
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
|
May 7 |
Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
|